Tag

UF Health

UF, UF Health Announce New Research and Technology Incubator

The University of Florida and the Norman Fixel Institute for Neurological Diseases at UF Health announced today the creation of a new Research and Technology Innovation Incubator. Selected for support through UF President Ben Sasse’s strategic funding process, this 20,000-square-foot space will serve as a state-of-the-art hub for interdisciplinary collaborations among the colleges. The $960,000 initiative also will establish the Fixel Institute as an international destination for leading-edge science and collaboration.

Making an Impact on Movement Disorders

AI applications for improving treatment for patients with movement disorders includes work by assistant professor Coralie de Hemptinne, PhD, MS, and biomedical scientist Jackson Cagle, PhD, researchers at the Norman Fixel Institute for Neurological Diseases at UF Health who have developed an algorithm to optimize deep brain stimulation, or DBS, a treatment that involves placing a thin wire in the brain in areas that control movement. Their technology, which received UF Innovate’s 2022 Invention of the Year award, predicts the best stimulation settings based on individual brain activity, shortening the wait to see improvement in symptoms.

Clinical Spotlight: UF Health Aortic Disease Center Celebrates Five Years

As of 2023, the team at UF Health's Aortic Disease Center has surpassed their 2018 goals of increasing case volume, broadening research, and improving the quality of treatment for patients. Led by Tom Martin, M.D., the center is also leveraging AI to improve the future of health care and put patients first.

Nci Grant Funds Study of Cancer Cachexia

Sarah Judge, Ph.D., a research assistant professor in the University of Florida College of Public Health and Health Professions, has received a $2.4 million, five-year grant from the National Cancer Institute to study the role of a key protein in driving cancer cachexia. Cancer cachexia, which is highly prevalent in cancers of the pancreas and gastrointestinal tract, is a frequent complication of cancer involving muscle wasting and weakness. The breakdown of muscle tissue reduces patients’ physical function and worsens their quality of life. It also often negatively impacts their ability to withstand aggressive conventional cancer treatments and contributes to decreased survival. There are no known effective therapies to preserve or reverse the loss of muscle mass in patients with cancer.

Scientists Train AI To Illuminate Drugs’ Impact on Cellular Targets

An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult. Now, an international team led by neuroscientist Kirill Martemyanov, Ph.D., based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is training artificial intelligence to assist.

A New Way To Capture Cancer Cells’ Symphony

A team of UF researchers has shed new light on the functional mechanisms of spontaneous calcium waves in human colon and prostate cancer cells. These findings could contribute to the development of innovative therapies for tumor suppression.

UF Health Cancer Center Hosts 3rd Annual AI Day

The UF Health Cancer Center hosted its 3rd Annual AI Day in Cancer Research, drawing speakers and attendees from a range of disciplines, such as engineering, public health, data science, and radiology, to learn more about the role of AI in cancer research.